NEXT VENTŪRES

We invest in exceptional founders and empower them with our expertise and time in exchange for equity, building impactful digital experiences that leave a mark on the world. Partnering with you From ideation to launch, we work with you step-by-step to build an innovative business model, develop viable prototypes, and rigorously test your product until it achieves market fit. Our venture strategy, ideation and validation, MVP launch, continuous delivery, and venture growth services are designed to free up your valuable time and accelerate your growth. Investing more than funds Unlock the potential growth of mid-stage startups with a proven core business model, focusing on the Wealthtech & Healthtech. We invest more than funds - our expertise supports you in every step of your digital product journey. Our goal is your successUnderstand: Together, we developer an innovative business model, contact potential industry partners, and implement an initial proof. Explore: We explore viable concepts and prototypes and develop user-centered products that deliver the "wow" factor. Validate: We rigorously test products with real customers and refine, refine, and refine again until we find the market fit. Launch: Engagement soars as we implement a future-proofed digital experience that your clients love. Our offer Partnering with entrepreneurs and co-founders, we support them as they scale to exit, giving them access to our global networks and services they need to grow. Venture strategy: From your idea to business model to value proposition, we work to find the right product market fit and validate these models and hypotheses with real customers. Venture ideation & validation: We build visual concepts and prototypes from your ideas, test them with real customers, and validate them with real feedback. MVP launch: We identify and define high-value, "wowable" products based on customer validation and feedback, creating a roadmap of clear increments to help the delivery plan. Continuous delivery: We work with founders and teams to successfully execute a continuous delivery and deployment program. Venture growth: We support your growth by working with you to find the right partners and opportunities.

SCOR Ventures is the venture investment arm of SCOR Reinsurance, responsible for both investing in and creating partnerships with startups across the insurtech landscape. Since 2017 we have built a global portfolio across three theses: (1) investing in tech-driven underwriting companies (MGAs, carriers) and distributors, (2) software solutions that benefit SCOR and/or our clients, and (3) companies that help people live healthier lives. Our investment scope includes both investments and commercial (re)insurance relationships with startups. We predominantly invest at late Seed / Series A and are interested in a broad range of B2B and B2B2C solutions across MedTech, wellness, wearables, data platforms, and software / AI platforms. What we’re looking for We invest across three thesis areas: Thesis 1: we invest and partner in the ‘Insurers of the Future’: tech-driven underwriting companies (MGAs, carriers) that offer multiple points of digital and business model differentiation across P&C and L&H. We provide direct access to SCOR expertise and our global network to help portfolio companies scale and/or access (re)insurance capacity. With a proven track record of supporting innovative underwriting propositions across multiple lines of business, we understand product development, program structuring, underwriting, pricing and distribution and thus have the capabilities to optimise partnerships between insurtechs and business partners. We predominantly invest at late Seed / Series A. We are class of business agnostic and have partnered with companies across a broad variety of personal and specialty lines. Thesis 2: we invest and partner in software solutions that benefit SCOR and/or our clients. We provide a broad understanding of the interests and pain points of insurers across the world, and the potential to connect companies with insurers through SCOR’s client services initiatives. We predominantly invest later stage vs. Thesis 1 (typically Series A-B) but have occasional appetite for Seed. We prioritise companies: developing data, tools, and methods for obtaining, understanding, pricing and transferring large portfolios of pre-aggregated risks, high-value individual risks such as energy facilities and construction mega-projects, and MGA/coverholder business delivering economically valuable additional services offering a visible outcome which can be used to boost client management or reduce risks. Focus areas include front-end (e.g., underwriting & pricing) policy administration, modelling, risk analytics, and claims developing platforms where insurance has not previously been embedded / distributed, but where SCOR Ventures sees substantial opportunities to close the global protection gap – e.g., marketplaces, “super apps”, b2b fintech, employee benefits working to solve climate and ESG challenges to support the net zero transition and cut emissions for SCOR and SCOR clients. Focus areas include ESG reporting, climate risk analysis and data, carbon offsetting as a solution, circular economy, diversity, equity, and inclusion (DEI) tech, and supply chain transparency. We also see several opportunities in the green insurance product space including solar production or maintenance guarantees, wind input parametric products, solar physical asset damage, cat-bond / ILS and insuring carbon credit projects. Thesis 3: We invest at the intersection of health and technology and partner with companies that help people live healthier lives, deliver in-force or claims outcome improvements, develop new business or add to SCOR’s Knowledge Center capabilities, and assist our clients to transform their offerings. We predominantly invest at late Seed / Series A and are interested in a broad range of B2B and B2B2C solutions across MedTech, wellness, wearables, data platforms, and software / AI platforms. How we operateIntegrated in the wider SCOR business: Direct access to the entirety of SCOR’s capabilities brings unique added value to our portfolio companies. SCOR’s core business has experts in nearly every country, line of business, and functional area, while SCOR Partners bring a broad range of client services, marketing and product development expertise. Mandate: focused on key markets in North America, EMEA and LATAM, with selective deployment in APAC and Africa. Stage and ownership: We invest Seed to Series B. We typically seek greater than 5% ownership at first investment, which may include a board seat (we have led or co-led half of our investments to date). Our investment is intended to make SCOR a meaningful contributor but leave founders room to manage their cap table. We look for a long-term investment and / or commercial relationship but do not seek a fast exit or to ultimately acquire portfolio companies. Partnership approach: we are active supporters of the companies we work with, assisting with technical input, recruitment, capital optimisation and more. The material growth of many insurtech MGAs and carriers has led to increasing demand for (re)insurance capacity; SCOR is a transparent, long-term partner. Insurtechs in SaaS and services segments, meanwhile, have benefited from SCOR’s long-standing client relationships, while SCOR benefits from bringing knowledge, links, and expertise regarding services with genuine value to our clients. We bring value to our portfolio companies by connecting them with other partner companies, as well as with founders and distribution leads in our network. Why partner with SCOR VenturesWe believe in fewer, deeper relationships over the long term. We are flexible and collaborative in our approach, tailoring a solution to your specific needs, in partnership with other insurers, reinsurers, and investors involved in your company as appropriate. We underwrite most major lines of business and geographies globally. We have a global network including insurance licenses but not a competing retail insurance arm. Insurers are our clients, so working with us does not limit your options to associate with insurers. In selected circumstances, we can offer access to Lloyd’s or SCOR’s insurance licenses in the U.S., Europe, Asia, Brazil, South Africa, and other markets. We look to move quickly with direct access to decision makers, whilst leveraging resources and expertise to ensure our partners can build relationships with the appropriate parts of our organization.

We’re more than invested. What we work on, and who we work with, matters. If we’re betting on you, there’s a good reason for it. We admire your drive and desire to solve big problems. We love to fuel progress and help bring new ideas to life. Our approach separates us from typical investors. We don’t just fund and forget. We’re in the trenches with you, helping you problem-solve and navigate what’s next. That’s the part we like. In short, we are tenacious advocates for early-stage companies. We offer capital and guidance for like-minded entrepreneurs in multiple industries, with a focus on digital health and wellness, as well as financial technology. We’ve been down this road before. For over a decade, we spent our time and energy growing businesses and backing early-stage, financial technology ventures. We had a knack for guiding new entrepreneurs and took great pride in seeing them flourish. With our fintech strategy firmly established, we decided to add a new area of focus. We spent two years examining trends and looking at our core beliefs. We care deeply about backing idea-driven technology companies that change the world in positive ways. Ultimately, we realized digital health and wellness was the perfect place to focus. For us, it’s a natural addition. We’ve built and scaled businesses before. We understand complex, highly-regulated industries. And we’re still using our grit and determination to invest in technology that improves wellbeing. Moving forward, we’ll continue to invest in companies that fit our ethos. Although to us, it’s more than investing. We’re helping build companies that find better solutions to real problems.

Canada’s leading digital healthcare Venture Capital firm, offering local depth with global reach. We are healthcare practitioners, operators and founders with over 100 years’ experience and a deep network. We focus on early stage and high-growth companies shaping the future of healthcare delivery and empowering them to scale and grow. How We InvestStage: Investments will be in early stage companies ranging from pre-Seed rounds through pre-IPO with initial investments focused on Seed and Series A rounds Areas: We look for groundbreaking HealthTech ideas focusing on digitization of healthcare, emergence of consumer MedTech, and consumerization of health and wellness Locations: We invest primarily in companies located in Canada, the US and Israel that target markets in North America and Europe

For nearly thirty years, RRE Ventures has been a leading venture capital firm in New York with nearly $2.5B under management and +400 portfolio companies. With over 25 IPOs and dozens of trade sales through the years, there is a lot going on at any given time. Recent well-known companies include Datadog, Venmo, Braintree, DCG, Noom, Kindbody, Spring Health, Olo, and BuzzFeed, among many other category-defining businesses. We pride ourselves not only on investing in great entrepreneurs and delivering stellar returns to our LPs but also on being supportive partners to our portfolio companies and active members of the venture community.

We build and invest in companies that positively impact human health with smart solutions, breakthrough science and technology. Our focus is on innovation in digital healthcare, connected medical devices, and life sciences We focus on therapeutic and preventive technology solutions addressing unmet needs in some of the most vulnerable segments of society: women, children and the elderly. Digital transformation will continue to shape our lives and has the potential to transform care. We aim to build and support Digital Health & Life Sciences companies working to make healthcare smarter, using data to improve care and outcomes, and reinventing the patient journey. Our vision for the future of healthcare guides our investment strategy. A data driven digital transformation will shape the future of healthcare. The traditional biopharma model will evolve into an integrated model, where prevention, precision cure, and care management will coexist in a highly personalized patient-centric solution. Our goal is to support the creation of life transforming care products and therapies. We believe the future of healthcare lies in supporting the next-generation of founders and teams who will lead us there. What do we look for?Innovation and groundbreaking opportunities in our sectors of focus: digital health, life sciences, tech-enabled care delivery, and connected devices Innovative treatments for Central Nervous System (CNS) disorders, in particular neurodevelopmental disorders, mental health and epilepsy Founders and teams with domain expertise who seek collaborative investment partners Investments that span development and commercial phases, with a focus on early stage opportunities (Pre-Seed to Series A). Our investment approachOur investment approach combines direct investments in early-stage companies with venture creation from bold ideas in global innovation hubs Our goal is to enable talented entrepreneurs to scale more quickly and effectively through access to our capital, enterprise capabilities and consumer touchpoints, while offering expertise and insights from Angelini’s unique perspective. We invest primarily across Europe, North America and Israel, recognizing that healthcare technology innovation is occurring in many cities around the world. We have committed €300M for investments and company creation in digital health and life sciences. What do we commit to you?Active and involved healthcare investors who operate with integrity, approachability, and transparency A team of passionate healthcare and venture capital experts diverse in demographic and experience A track record of success and experience navigating the ups and downs of early-stage company building Access to a world-class advisory board to leverage C-level experience, expertise, and leadership in healthcare